DOXYCYCLINE HYCLATE
- Product NDC
- 55488-0186
- Requested package NDC
- 55488-0186-2
- 11-digit product format
- 554880186
- Labeler code
- 55488
- Product ID
- 55488-0186_47a38f08-ac1a-4c1d-97e6-086604822af4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DOXYCYCLINE HYCLATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Changzhou Pharmaceutical Factory
- Application
- ANDA209402
- Marketing category
- ANDA
- Marketing start
- 2020-05-28
- Marketing end
- 0000-00-00
- Substance
- DOXYCYCLINE HYCLATE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Tetracycline-class Drug [EPC],Tetracyclines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55488-0186 | 55488-0186-2 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209402-001 | DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2019-10-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209402-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209402-001 | DOXYCYCLINE HYCLATE | EQ 100MG BASE | CAPSULE / ORAL | AB | 2019-10-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209402-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| doxycycline | DOXYCYCLINE | Preferred Pharmaceuticals Inc. | bcc95094-80ed-4023-b2a6-955a4810bfbe | 2026-07-30 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | REMEDYREPACK INC. | d3c0b756-30ba-4ef9-a178-fd785d720373 | 2026-05-20 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | REMEDYREPACK INC. | f0fbf63a-e75c-40cf-b2e9-429deaac899d | 2026-05-06 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | ST. MARY'S MEDICAL PARK PHARMACY | 00b2aa98-dea2-90c3-e063-6294a90a35d6 | 2026-05-01 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | Preferred Pharmaceuticals Inc. | 7f882f1a-fe75-4592-9df5-f0e4bf1d232e | 2026-04-08 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | A-S Medication Solutions | 1c998ca8-1df6-4b3c-9533-f4500cc1079a | 2026-02-10 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | A-S Medication Solutions | fe8cd3c6-36d6-4d92-bc5c-833cd6f9cb32 | 2026-02-10 | Warnings, Adverse reactions | 209402 ANDA209402 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Health Department, Oklahoma State | f39365f9-eb64-00cb-e053-2995a90a8d80 | 2025-12-31 | Warnings | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | Cranbury Pharmaceuticals, LLC | 43ceb0ee-268a-424c-a6a8-88e824c5ed04 | 2025-11-04 | Warnings, Adverse reactions | 209402 ANDA209402 |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Diirect_rx | 1b403f4b-1c61-3991-e063-6394a90ae4f2 | 2024-12-02 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | Bryant Ranch Prepack | 1df9e905-d2e7-4a5a-8bd6-43f4850ba900 | 2024-08-21 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | Proficient Rx LP | 716dccec-7480-44dd-91b9-249ae2c25088 | 2024-08-01 | Warnings, Adverse reactions | 209402 ANDA209402 |
| doxycycline | DOXYCYCLINE | Asclemed USA, Inc. | f33ae6f5-bdb6-4c15-9e62-6180433bb1fb | 2023-05-04 | Warnings, Adverse reactions | 209402 ANDA209402 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b4321c75-2e87-4d90-9726-9a28fb2293a3 | Product name | 3 | 20260112 |
| 5e99724e-0654-4aec-b7a2-0b9b10e312ee | Product name | 3 | 20250227 |
| d2d36660-68ce-7e7d-0630-ec4b0d859fad | Product name | 6 | 20220921 |
| a239f4dd-cf93-4660-b190-f97d000f249f | Product name | 7 | 20210607 |
| a9d03566-caeb-4466-8021-74599b048880 | Product name | 3 | 20210604 |
| 12750814-20f7-4f35-b5fa-dbc8811ba858 | Product name | 9 | 20201007 |
| 00a5dbaa-1b7d-4e56-be0c-fedc7bbf5ade | Product name | 1 | 20200706 |
| 7b4b06ac-8c50-45f0-9556-293ea558a294 | Product name | 1 | 20180808 |
| 6a5b4392-5ab0-af0d-e0be-47b34e9dbb84 | Product name | 5 | 20171121 |
| 01a4aa74-7e05-63bd-bc10-1b5ceb111371 | Product name | 2 | 20171115 |
| 58b1278c-6dce-49b6-a05e-ea16f389acba | Product name | 1 | 20160620 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55488-0186-1 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-7db6-a426-e053-dadaa90af4c2 | DOXYCYCLINE HYCLATE CAPSULES - for oral use |
| 55488-0186-2 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-7db6-a426-e053-dadaa90af4c2 | DOXYCYCLINE HYCLATE CAPSULES - for oral use |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55488-0186-1 | DOXYCYCLINE HYCLATE | 50 in 1 BOTTLE | CAPSULE | 50 | 2 | |
| 55488-0186-2 | DOXYCYCLINE HYCLATE | 500 in 1 BOTTLE | CAPSULE | 500 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55488-0186 | DOXYCYCLINE HYCLATE CAPSULE [CHANGZHOU PHARMACEUTICAL FACTORY] | 2 | Legacy NDC, 2 package rows | 20201029_045c1a20-4fe5-49b1-ad43-d92464e42ec7.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1649988 | doxycycline hyclate 100 MG Oral Capsule | PSN | 045c1a20-4fe5-49b1-ad43-d92464e42ec7 | 2 |
| 1649988 | doxycycline hyclate 100 MG Oral Capsule | SCD | 045c1a20-4fe5-49b1-ad43-d92464e42ec7 | 2 |
| 1649988 | doxycycline (as doxycycline hyclate) 100 MG Oral Capsule | SY | 045c1a20-4fe5-49b1-ad43-d92464e42ec7 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55488-0186-2 | 55488018602 | 500 CAPSULE in 1 BOTTLE (55488-0186-2) | 500 capsule | 2020-05-28 | 0000-00-00 | No | No | Current |